13.25
Precedente Chiudi:
$13.19
Aprire:
$13.05
Volume 24 ore:
207.61K
Relative Volume:
0.71
Capitalizzazione di mercato:
$653.41M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-14.13%
1M Prestazione:
-1.71%
6M Prestazione:
+26.43%
1 anno Prestazione:
+0.00%
Jade Biosciences Inc Stock (JBIO) Company Profile
Nome
Jade Biosciences Inc
Settore
Industria
Telefono
(781) 312-3013
Indirizzo
221 CRESCENT ST., WALTHAM
Confronta JBIO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
JBIO
Jade Biosciences Inc
|
13.25 | 650.21M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.68 | 122.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
801.01 | 85.37B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
399.40 | 55.82B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
795.57 | 50.67B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
170.27 | 37.54B | 447.02M | -1.18B | -906.14M | -6.1812 |
Jade Biosciences Inc Stock (JBIO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-09 | Iniziato | BTIG Research | Buy |
| 2025-07-14 | Iniziato | Jefferies | Buy |
| 2025-06-16 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2025-05-07 | Iniziato | Wedbush | Outperform |
| 2025-05-05 | Iniziato | Stifel | Buy |
| 2025-05-02 | Iniziato | TD Cowen | Buy |
| 2024-06-18 | Downgrade | Evercore ISI | Outperform → In-line |
| 2024-06-18 | Downgrade | TD Cowen | Buy → Hold |
| 2024-06-18 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2024-06-17 | Downgrade | BTIG Research | Buy → Neutral |
| 2024-06-17 | Downgrade | Guggenheim | Buy → Neutral |
| 2024-06-17 | Downgrade | Wedbush | Outperform → Neutral |
| 2024-03-25 | Ripresa | Jefferies | Buy |
| 2023-12-08 | Iniziato | Wells Fargo | Equal Weight |
| 2023-03-01 | Iniziato | Guggenheim | Buy |
| 2022-12-06 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2022-09-19 | Ripresa | Wedbush | Outperform |
| 2022-08-16 | Downgrade | BTIG Research | Buy → Neutral |
| 2022-02-11 | Iniziato | BTIG Research | Buy |
| 2021-07-26 | Iniziato | Cowen | Outperform |
| 2021-07-26 | Iniziato | Evercore ISI | Outperform |
| 2021-07-26 | Iniziato | Jefferies | Buy |
| 2021-07-26 | Iniziato | Wedbush | Outperform |
Mostra tutto
Jade Biosciences Inc Borsa (JBIO) Ultime notizie
Jade Biosciences (NASDAQ:JBIO) Coverage Initiated at HC Wainwright - Defense World
Why Jade Biosciences Inc. stock is popular among millennialsQuarterly Portfolio Review & Daily Growth Stock Tips - ulpravda.ru
Will Jade Biosciences Inc. stock benefit from sector rotationPortfolio Performance Summary & Stepwise Trade Signal Implementation - ulpravda.ru
How Jade Biosciences Inc. stock reacts to job market dataJuly 2025 Volume & Weekly Watchlist for Hot Stocks - ulpravda.ru
How Jade Biosciences Inc. stock reacts to global recession fearsPortfolio Value Report & Short-Term Swing Trade Alerts - ulpravda.ru
Why Jade Biosciences Inc. stock remains a top recommendationMarket Activity Report & Expert Approved Momentum Ideas - ulpravda.ru
H.C. Wainwright initiates coverage on Jade Biosciences stock with Buy rating - Investing.com Canada
This Applied Digital Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Wednesday - Benzinga
HC Wainwright & Co. Initiates Coverage of Jade Biosciences (JBIO) with Buy Recommendation - Nasdaq
Will Jade Biosciences Inc. stock rally after Fed decisions2026 world cup usa national team semifinals star players counter attacking odds analysis preview - ulpravda.ru
Does Jade Biosciences, Inc. (JBIO) have the potential to rally 65% as Wall Street analysts expect? - MSN
The recent drop in prices must have disappointed Jade Biosciences, Inc. (NASDAQ:JBIO) institutional investors who own 53% of the shares - simplywall.st
Institutional investors in Jade Biosciences, Inc. (NASDAQ:JBIO) must be dismayed after prices dropped by 16% last week - Yahoo Finance
Jade Biosciences outlines 2026 clinical pipeline and milestones By Investing.com - Investing.com Nigeria
Jade Biosciences (NASDAQ:JBIO) Shares Gap DownTime to Sell? - MarketBeat
Jade Biosciences Outlines 2026 Autoimmune Pipeline Priorities - TipRanks
Jade Biosciences outlines 2026 clinical pipeline and milestones - Investing.com
Jade Biosciences Outlines Key 2026 Objectives and Strategy - GlobeNewswire
Jade Biosciences (NASDAQ:JBIO) Trading Down 3.7%Here's Why - MarketBeat
Wall Street Analysts Predict a 52.5% Upside in Jade Biosciences, Inc. (JBIO): Here's What You Should Know - MSN
Jade Biosciences (NASDAQ:JBIO) Stock Price Up 4.5%Here's What Happened - MarketBeat
Wedbush Adjusts Price Target on Jade Biosciences to $24 From $19, Maintains Outperform Rating - MarketScreener
Jade Biosciences, Inc. (NASDAQ:JBIO) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Volume Report: Why Jade Biosciences Inc stock is popular among millennials2025 Technical Patterns & Daily Growth Stock Tips - moha.gov.vn
Jade Biosciences, Inc. (NASDAQ:JBIO) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World
Jade Biosciences files for offering of 3.2 million shares of common stock by selling stockholderSEC filing - marketscreener.com
Jade Biosciences (NASDAQ:JBIO) Trading Down 4.5%Here's What Happened - MarketBeat
What analysts say about Jade Biosciences Inc stockStock Liquidity Analysis & Unlock Long-Term Capital Growth Ideas - earlytimes.in
Jade Biosciences Inc JBIO’s stock price gains traction on Friday - uspostnews.com
Is Jade Biosciences Inc. stock supported by strong cash flowsGap Down & Real-Time Chart Pattern Alerts - Улправда
Why Jade Biosciences Inc. stock is a value investor pickPortfolio Return Report & Accurate Intraday Trading Signals - Улправда
Is Jade Biosciences Inc. stock resilient to inflationWeekly Trade Recap & Capital Protection Trading Alerts - Улправда
Form 424B3 Jade Biosciences, Inc. - StreetInsider
Published on: 2025-12-19 20:08:24 - Улправда
Is Jade Biosciences Inc. stock a safe investment in uncertain marketsGap Up & AI Forecasted Entry/Exit Points - Улправда
How risky is Jade Biosciences Inc. stock nowMarket Trend Report & Daily Momentum Trading Reports - DonanımHaber
What analyst consensus says on Jade Biosciences Inc. stock2025 Trade Ideas & Fast Entry Momentum Alerts - Улправда
JBIO Surges Over 75% In Just Two Months On Pipeline MomentumDid You Take The Bet? - RTTNews
Latham & Watkins Advises Jade Biosciences on US$45 Million Private Placement - Legal Desire Media and Insights
Jade Biosciences prices 3.21M shares at $14.00 in private placement - MSN
Jade Biosciences secures $45 million in private placement from BB Biotech - Investing.com Nigeria
Jade Biosciences secures $45 million in private placement from BB Biotech By Investing.com - Investing.com South Africa
Jade Biosciences Says to Raise $45 Million via Private Placement of 3.2 Million Shares - marketscreener.com
Jade Biosciences announces $45 million private placement - marketscreener.com
Jade Biosciences Announces $45 Million Private Placement - GlobeNewswire
Frazier Life Sciences Management L.P. Makes New $17.70 Million Investment in Jade Biosciences, Inc. $JBIO - MarketBeat
Jade Biosciences (NASDAQ:JBIO) Trading 7.4% HigherHere's What Happened - MarketBeat
Jade Biosciences, Inc. announced that it expects to receive $45.000004 million in funding - marketscreener.com
Jade Biosciences (JBIO): Analyst Lauds Entry into Market - Finviz
Jade Biosciences (JBIO): Analyst lauds entry into market - MSN
Jade Biosciences Inc Azioni (JBIO) Dati Finanziari
Non sono disponibili dati finanziari per Jade Biosciences Inc (JBIO). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):